PRTAV

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Prothena Corp. Plc - Ordinary Shares (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRTAV

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
10/27/2022	4:05PM	GlobeNewswire Inc.	Prothena to Report Third Quarter 2022 Financial Results on November 3rd	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
09/01/2022	4:20PM	GlobeNewswire Inc.	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
09/01/2022	4:05PM	GlobeNewswire Inc.	Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
08/08/2022	4:05PM	GlobeNewswire Inc.	Prothena Reports Second Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
08/02/2022	4:05PM	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
08/01/2022	4:05PM	GlobeNewswire Inc.	Prothena to Report Second Quarter 2022 Financial Results on August 8th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
07/01/2022	4:16PM	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
06/02/2022	4:05PM	GlobeNewswire Inc.	Prothena to Participate in Jefferies Healthcare Conference	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
05/05/2022	4:05PM	GlobeNewswire Inc.	Prothena Reports First Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
04/28/2022	4:05PM	GlobeNewswire Inc.	Prothena to Report First Quarter 2022 Financial Results on May 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
04/26/2022	8:30AM	GlobeNewswire Inc.	Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
03/28/2022	8:30AM	GlobeNewswire Inc.	Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
03/21/2022	4:05PM	GlobeNewswire Inc.	Prothena to Participate in Stifel 2022 Virtual CNS Days	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
03/16/2022	5:30AM	GlobeNewswire Inc.	Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
02/17/2022	4:05PM	GlobeNewswire Inc.	Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
02/10/2022	4:05PM	GlobeNewswire Inc.	Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
11/29/2021	4:05PM	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Hematology and Oncology Summit	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
11/04/2021	4:05PM	GlobeNewswire Inc.	Prothena Reports Third Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
10/28/2021	4:05PM	GlobeNewswire Inc.	Prothena to Report Third Quarter 2021 Financial Results on November 4th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
10/01/2021	4:30PM	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
10/01/2021	4:05PM	GlobeNewswire Inc.	Prothena Announces Executive Appointments	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
09/03/2021	4:05PM	GlobeNewswire Inc.	Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
09/01/2021	4:05PM	GlobeNewswire Inc.	Prothena to Participate in Upcoming September Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
08/05/2021	4:05PM	GlobeNewswire Inc.	Prothena Reports Second Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
07/29/2021	4:05PM	GlobeNewswire Inc.	Prothena to Report Second Quarter 2021 Financial Results on August 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
07/26/2021	9:00AM	GlobeNewswire Inc.	Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
07/20/2021	4:05PM	GlobeNewswire Inc.	Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
07/12/2021	7:00AM	GlobeNewswire Inc.	Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
06/24/2021	8:30AM	GlobeNewswire Inc.	Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
06/10/2021	2:18PM	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Life Sciences Conference on June 16	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)